IL147242A0 - Taste masking of oral quinolone liquid preparations using ion exchange resins - Google Patents
Taste masking of oral quinolone liquid preparations using ion exchange resinsInfo
- Publication number
- IL147242A0 IL147242A0 IL14724200A IL14724200A IL147242A0 IL 147242 A0 IL147242 A0 IL 147242A0 IL 14724200 A IL14724200 A IL 14724200A IL 14724200 A IL14724200 A IL 14724200A IL 147242 A0 IL147242 A0 IL 147242A0
- Authority
- IL
- Israel
- Prior art keywords
- ion exchange
- exchange resins
- liquid preparations
- taste masking
- quinolone
- Prior art date
Links
- 239000003456 ion exchange resin Substances 0.000 title 1
- 229920003303 ion-exchange polymer Polymers 0.000 title 1
- 239000007788 liquid Substances 0.000 title 1
- 230000000873 masking effect Effects 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35354999A | 1999-07-14 | 1999-07-14 | |
| PCT/US2000/018948 WO2001005431A1 (en) | 1999-07-14 | 2000-07-12 | Taste masking of oral quinolone liquid preparations using ion exchange resins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL147242A0 true IL147242A0 (en) | 2002-08-14 |
Family
ID=23389610
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14724200A IL147242A0 (en) | 1999-07-14 | 2000-07-12 | Taste masking of oral quinolone liquid preparations using ion exchange resins |
| IL147242A IL147242A (en) | 1999-07-14 | 2001-12-23 | Camouflage of taste of liquid quinolone preparations given orally by using a resin ion exchanger |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL147242A IL147242A (en) | 1999-07-14 | 2001-12-23 | Camouflage of taste of liquid quinolone preparations given orally by using a resin ion exchanger |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1200129B1 (cs) |
| JP (2) | JP2003504416A (cs) |
| AR (1) | AR024715A1 (cs) |
| AT (1) | ATE411047T1 (cs) |
| AU (1) | AU777993B2 (cs) |
| BG (1) | BG65656B1 (cs) |
| BR (1) | BR0012439A (cs) |
| CA (1) | CA2378894C (cs) |
| CY (1) | CY1108801T1 (cs) |
| CZ (1) | CZ302919B6 (cs) |
| DE (1) | DE60040540D1 (cs) |
| DK (1) | DK1200129T3 (cs) |
| ES (1) | ES2313897T3 (cs) |
| HU (1) | HUP0202229A3 (cs) |
| IL (2) | IL147242A0 (cs) |
| MX (1) | MXPA02000501A (cs) |
| NO (1) | NO20020134L (cs) |
| NZ (1) | NZ516536A (cs) |
| PL (1) | PL202027B1 (cs) |
| PT (1) | PT1200129E (cs) |
| SI (1) | SI1200129T1 (cs) |
| SK (1) | SK287415B6 (cs) |
| WO (1) | WO2001005431A1 (cs) |
| ZA (1) | ZA200200026B (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6589955B2 (en) | 2001-06-20 | 2003-07-08 | Bristol-Myers Squibb Company | Pediatric formulation of gatifloxacin |
| DE10224086A1 (de) * | 2002-05-31 | 2003-12-11 | Bayer Ag | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
| JP5009707B2 (ja) * | 2007-07-10 | 2012-08-22 | 東和薬品株式会社 | 不快な味がマスキングされたキノロン系抗菌剤の経口投与用液剤 |
| PL2572717T3 (pl) * | 2010-05-19 | 2016-12-30 | Kompozycja farmaceutyczna zawierająca solifenacynę |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4788055A (en) * | 1985-12-09 | 1988-11-29 | Ciba-Geigy Corporation | Resinate sustained release dextromethorphan composition |
| US4808411A (en) * | 1987-06-05 | 1989-02-28 | Abbott Laboratories | Antibiotic-polymer compositions |
| DE3719764A1 (de) * | 1987-06-13 | 1988-12-22 | Bayer Ag | Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung |
| IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it |
| US4996047A (en) * | 1988-11-02 | 1991-02-26 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
| US5275820A (en) * | 1990-12-27 | 1994-01-04 | Allergan, Inc. | Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles |
| DK0604570T3 (da) * | 1991-09-17 | 1998-09-14 | Alcon Lab Inc | Præparater, der indeholder quinolon-antibiotika og sulfonat af polystyren |
| CA2122286A1 (en) * | 1993-04-28 | 1994-10-29 | Hiroshi Matoba | Solid preparation and its production |
| JPH0710747A (ja) * | 1993-04-28 | 1995-01-13 | Takeda Chem Ind Ltd | 固形製剤およびその製造方法 |
| JP2000103730A (ja) * | 1998-07-31 | 2000-04-11 | Otsuka Pharmaceut Co Ltd | 服用感が改善された医薬組成物 |
-
2000
- 2000-07-12 CZ CZ20020071A patent/CZ302919B6/cs not_active IP Right Cessation
- 2000-07-12 SI SI200031014T patent/SI1200129T1/sl unknown
- 2000-07-12 PT PT00945340T patent/PT1200129E/pt unknown
- 2000-07-12 CA CA002378894A patent/CA2378894C/en not_active Expired - Lifetime
- 2000-07-12 JP JP2001510519A patent/JP2003504416A/ja active Pending
- 2000-07-12 NZ NZ516536A patent/NZ516536A/en not_active IP Right Cessation
- 2000-07-12 IL IL14724200A patent/IL147242A0/xx unknown
- 2000-07-12 HU HU0202229A patent/HUP0202229A3/hu not_active Application Discontinuation
- 2000-07-12 AT AT00945340T patent/ATE411047T1/de active
- 2000-07-12 EP EP00945340A patent/EP1200129B1/en not_active Expired - Lifetime
- 2000-07-12 WO PCT/US2000/018948 patent/WO2001005431A1/en active IP Right Grant
- 2000-07-12 DE DE60040540T patent/DE60040540D1/de not_active Expired - Lifetime
- 2000-07-12 DK DK00945340T patent/DK1200129T3/da active
- 2000-07-12 BR BR0012439-7A patent/BR0012439A/pt not_active Application Discontinuation
- 2000-07-12 SK SK53-2002A patent/SK287415B6/sk not_active IP Right Cessation
- 2000-07-12 PL PL352183A patent/PL202027B1/pl not_active IP Right Cessation
- 2000-07-12 MX MXPA02000501A patent/MXPA02000501A/es active IP Right Grant
- 2000-07-12 AU AU59302/00A patent/AU777993B2/en not_active Ceased
- 2000-07-12 ES ES00945340T patent/ES2313897T3/es not_active Expired - Lifetime
- 2000-07-27 AR ARP000103565A patent/AR024715A1/es active IP Right Grant
-
2001
- 2001-12-23 IL IL147242A patent/IL147242A/en not_active IP Right Cessation
-
2002
- 2002-01-02 ZA ZA200200026A patent/ZA200200026B/en unknown
- 2002-01-11 NO NO20020134A patent/NO20020134L/no unknown
- 2002-01-21 BG BG106329A patent/BG65656B1/bg unknown
-
2008
- 2008-12-31 CY CY20081101520T patent/CY1108801T1/el unknown
-
2011
- 2011-09-12 JP JP2011198876A patent/JP2011246497A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0202229A2 (hu) | 2002-11-28 |
| SK532002A3 (en) | 2002-05-09 |
| IL147242A (en) | 2008-12-29 |
| AU5930200A (en) | 2001-02-05 |
| SI1200129T1 (sl) | 2009-06-30 |
| WO2001005431A1 (en) | 2001-01-25 |
| BG106329A (en) | 2002-08-30 |
| DE60040540D1 (de) | 2008-11-27 |
| NO20020134D0 (no) | 2002-01-11 |
| ES2313897T3 (es) | 2009-03-16 |
| BR0012439A (pt) | 2002-04-02 |
| PT1200129E (pt) | 2008-12-17 |
| DK1200129T3 (da) | 2009-01-12 |
| CZ302919B6 (cs) | 2012-01-18 |
| CZ200271A3 (cs) | 2002-04-17 |
| EP1200129A1 (en) | 2002-05-02 |
| PL352183A1 (en) | 2003-08-11 |
| JP2003504416A (ja) | 2003-02-04 |
| BG65656B1 (bg) | 2009-05-29 |
| HUP0202229A3 (en) | 2008-10-28 |
| SK287415B6 (sk) | 2010-09-07 |
| AR024715A1 (es) | 2002-10-23 |
| CA2378894A1 (en) | 2001-01-25 |
| NZ516536A (en) | 2003-09-26 |
| MXPA02000501A (es) | 2002-07-02 |
| ATE411047T1 (de) | 2008-10-15 |
| ZA200200026B (en) | 2003-04-02 |
| PL202027B1 (pl) | 2009-05-29 |
| CA2378894C (en) | 2005-11-22 |
| NO20020134L (no) | 2002-01-11 |
| CY1108801T1 (el) | 2012-05-23 |
| AU777993B2 (en) | 2004-11-11 |
| JP2011246497A (ja) | 2011-12-08 |
| EP1200129B1 (en) | 2008-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ20011518A3 (cs) | Farmaceutický prostředek | |
| HUP0201765A3 (en) | Taste masked pharmaceutical liquid formulations | |
| AU1998200A (en) | Multiparticulate oral dosage forms | |
| IL142642A0 (en) | Pharmaceutical moxifloxacin preparation | |
| IL148379A0 (en) | Pharmaceutical solutions of levosimendan | |
| AU2001269291A1 (en) | Therapeutic acridone and acridine compounds | |
| EG22530A (en) | Preparation of substituted piperidin-4-ones | |
| PL352062A1 (en) | Oral solution of prucalopride | |
| IL147242A0 (en) | Taste masking of oral quinolone liquid preparations using ion exchange resins | |
| HUP0201667A3 (en) | Oral form of administration | |
| AU6203001A (en) | Capsule for magnetic field therapy | |
| GB0029847D0 (en) | Preparation of spheroids | |
| ZA200400269B (en) | Pharmaceutical preparations containing ion exchange resins charged with fluoro-quinolone | |
| IL149534A0 (en) | Preparation of 3-substituted-4-arylquinolin-2-one derivatives | |
| AU2002345086A1 (en) | Pharmaceutical preparations containing ion exchange resins charged with fluoroquinolone | |
| IL147410A0 (en) | L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases | |
| IL144693A0 (en) | Preparation of carvone | |
| HUP0001558A3 (en) | Process for the preparation of pirlindole hydrochloride | |
| HUP9902855A3 (en) | Preparation of sterol- and stanol-esters | |
| GB9912167D0 (en) | Antiperspirant salts and methods of their preparation | |
| EP1201245A4 (en) | FUNCTIONAL ORAL PREPARATIONS | |
| GB2358188B (en) | Preparation of triarylamines | |
| AU7563100A (en) | Method of preparation of sildenafil | |
| SI1194153T1 (en) | Taste masked pharmaceutical liquid formulations | |
| AUPQ030599A0 (en) | Magnetic treatment of fluids |